HI
GILD icon

HBK Investments’s Gilead Sciences GILD Stock Holding History

HBK Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-50,200
Closed -$4.17M – 422
2023
Q1 		$4.17M Buy
+50,200
New +$4.16M 0.03% 106
2021
Q3 		– Sell
-26,600
Closed -$1.83M – 798
2021
Q2 		$1.83M Sell
26,600
-11,700
-31% -$781K 0.01% 511
2021
Q1 		$2.48M Buy
+38,300
New +$2.47M 0.01% 445
2018
Q4 		– Sell
-13,500
Closed -$1.04M – 1277
2018
Q3 		$1.04M Buy
+13,500
New +$1.02M 0.01% 706

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HBK Investments's GILD Position: Q2 2021 in Review

HBK Investments sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 5,459 shares — an estimated $365K sold.

HBK Investments first reported a position in GILD in Q3 2014 and held it in 22 quarters. The position peaked at $37.1M in Q2 2017. 1,545 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • HBK Investments reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • HBK Investments sold 5,459 Gilead Sciences shares in Q2 2021, an estimated $365K.
  • HBK Investments first reported a position in Gilead Sciences in Q3 2014 and held it in 22 quarters.
  • HBK Investments's Gilead Sciences position peaked at $37.1M in Q2 2017.
  • 1,545 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on HBK Investments's 13F filing for Q2 2021, filed 16 Aug 2021.